COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Ivermectin meta
12/27 Meta
Hill, A., Preprint (Preprint) (meta analysis)
Meta-analysis of clinical trials of ivermectin to treat COVID-19 infection
Source   PDF   Share   Tweet
WHO-funded meta analysis showing ivermectin treatment mortality relative risk RR 0.17 [0.08-0.35] for RCTs and RR 0.28 [0.13-0.62] for RCTs and observational studies, and confirming a dose-response effect.

Hill et al., 12/27/2020, preprint, 1 author.
Details of all 63 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit